NDC 68134-603

Clonidine

Clonidine

Clonidine is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Palmetto Pharmaceuticals Inc.. The primary component is Clonidine.

Product ID68134-603_e93324f1-ad82-7bbe-e053-2995a90a8c9e
NDC68134-603
Product TypeHuman Prescription Drug
Proprietary NameClonidine
Generic NameClonidine
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2022-03-01
Marketing CategoryNDA AUTHORIZED GENERIC /
Application NumberNDA022500
Labeler NamePALMETTO PHARMACEUTICALS INC.
Substance NameCLONIDINE
Active Ingredient Strength0 mg/1
Pharm ClassesAdrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 68134-603-30

30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68134-603-30)
Marketing Start Date2022-03-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Clonidine" or generic name "Clonidine"

NDCBrand NameGeneric Name
0378-0871Clonidineclonidine
0378-0872Clonidineclonidine
0378-0873Clonidineclonidine
39822-2000ClonidineClonidine
39822-2010ClonidineClonidine
50742-247Clonidineclonidine
51862-453ClonidineClonidine
51862-455ClonidineClonidine
51862-454ClonidineClonidine
65038-040ClonidineClonidine
65038-041ClonidineClonidine
65038-042ClonidineClonidine
21695-567Catapresclonidine
0597-0031Catapres-TTSclonidine
0597-0032Catapres-TTSclonidine
0597-0033Catapres-TTSclonidine
0591-3508Clonidine transdermal systemClonidine
0591-3509Clonidine transdermal systemClonidine
0591-3510Clonidine transdermal systemClonidine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.